Focus
View

VERTEX PHARMACEUTICALS INC / MA

VRTX · FY2025

ALIGNED

CEO Package

$21.1M

Pay Ratio

—

Reshma Kewalramani

Pay reset -1.8% while TSR improved +13.6 pts

ELI LILLY & Co

LLY · FY2025

MIXED

CEO Package

$36.7M

Pay Ratio

—

David A. Ricks

Pay and TSR both rose, but not in lockstep

JOHNSON & JOHNSON

JNJ · FY2025

ALIGNED

CEO Package

$32.8M

Pay Ratio

—

Joaquin Duato

Returns outran pay growth by +16.0 pts

CEOTotal Compensation — All Companies

VRTX$21.1MLLY$36.7MJNJ$32.8M

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

LLY carries the largest package at $36.7M, about 1.7x VRTX.
LLY reads mixed, while VRTX looks aligned.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

VRTX

Reshma Kewalramani

$21.1M

base salary8%
stock awards71%
non-equity incentive compensation19%
other compensation2%

LLY

David A. Ricks

$36.7M

base salary5%
stock awards64%
non-equity incentive compensation18%
other compensation2%

JNJ

Joaquin Duato

$32.8M

base salary5%
stock awards46%
option awards18%
non-equity incentive compensation13%
other compensation2%

Quick Comparison

CompanyCEOLatest YearTotal Comp
VERTEX PHARMACEUTICALS INC / MA(VRTX)Reshma Kewalramani2025$21.1M
ELI LILLY & Co(LLY)David A. Ricks2025$36.7M
JOHNSON & JOHNSON(JNJ)Joaquin Duato2025$32.8M

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.